Patient Engagement Solutions Market - 2026-2033

April 2026 | 54 pages | ID: P177D06921A3EN
DataM Intelligence

US$ 3,400.00 US$ 4,350.00 -22 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Patient Engagement Solutions Marketis is growing with a CAGR of 12.50% during the forecast period 2026-2035.

The Patient Engagement Solutions Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled market intelligence. This insightful report meticulously explores the competitive landscape, profiling key players and their forward-thinking innovations in product development, pricing strategies, financial metrics, and global expansion initiatives. By uncovering the driving forces, market dynamics, and disruptive trends shaping the future, this research equips industry stakeholders with the actionable insights needed to make informed decisions in an increasingly dynamic and competitive environment.

A Patient Engagement Solutions Market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.

By Product component
    • Hardware *
    • Software
    • Standalone Solutions
    • Integrated Solutions
    • Services
    • Consulting Services
    • Implementation Services
    • Training & Education Services
    • Post-sale & Maintenance Services
    • Advertising Services
    • Enrollment Services
By Mode of Delivery
    • On-Premise *
    • Web-based
    • Cloud-based
By Application
    • Health Management *
    • Social and Behavioral Management
    • Home Health Management
    • Financial Health Management
By End-user
    • Individual Users *
    • Providers
    • Hospitals
    • Physicians
    • Payers
    • Private
    • Government
    • Other End Users
By Therapeutic Area
    • Chronic Diseases *
    • Diabetes
    • Cardiovascular Disease
    • Obesity (Weight Loss Management)
    • Other Chronic Diseases
    • Women's Health
    • Fitness
    • Other Therapeutic Areas
Regional Analysis for Patient Engagement Solutions Market:
  • North America (U.S., Canada, Mexico)
  • Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
  • Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
  • South America (Colombia, Brazil, Argentina, Rest of South America)
  • Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
This Report Covers:
  • Go-to-market Strategy.
  • Neutral perspective on the market performance.
  • Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.
  • Customized regional/country reports as per request and country level analysis.
  • Potential & niche segments and regions exhibiting promising growth covered.
  • Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).
Research Process:

Both primary and secondary data sources have been used in the global Patient Engagement Solutions Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
1. METHODOLOGY AND SCOPE

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. DEFINITION AND OVERVIEW

3. EXECUTIVE SUMMARY

3.1. Market Snippet by Product component
3.2. Market Snippet by Mode of Delivery
3.3. Market Snippet by Application
3.4. Market Snippet by End-user
3.5. Market Snippet by Therapeutic Area

4. DYNAMICS

4.1. Market Impacting Factors
  4.1.1. Drivers
    4.1.1.1. The rise in the aging population
    4.1.1.2. The increasing burden of chronic diseases
    4.1.1.3. The rise in the focus of patients on self-managing their care
  4.1.2. Restraints
    4.1.2.1. Concerns related to the security of patient data
    4.1.2.2. The lack of interoperability
  4.1.3. Impact Analysis

5. INDUSTRY ANALYSIS

5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Regulatory Analysis
5.4. Pricing Analysis

6. BY PRODUCT COMPONENT

6.1. Introduction
6.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product component
6.3. Market Attractiveness Index, By Product component
  6.3.1. Hardware *
    6.3.1.1. Introduction
    6.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2020-2027
  6.3.2. Software
    6.3.2.1. Standalone Solutions
    6.3.2.2. Integrated Solutions
  6.3.3. Services
    6.3.3.1. Consulting Services
    6.3.3.2. Implementation Services
    6.3.3.3. Training & Education Services
    6.3.3.4. Post-sale & Maintenance Services
    6.3.3.5. Advertising Services
    6.3.3.6. Enrollment Services

7. BY MODE OF DELIVERY

7.1. Introduction
7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Mode of Delivery
7.3. Market Attractiveness Index, By Mode of Delivery
  7.3.1. On-Premise *
    7.3.1.1. Introduction
    7.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2020-2027
  7.3.2. Web-based
  7.3.3. Cloud-based

8. BY APPLICATION

8.1. Introduction
8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
8.3. Market Attractiveness Index, By Application
  8.3.1. Health Management *
    8.3.1.1. Introduction
    8.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2020-2027
  8.3.2. Social and Behavioral Management
  8.3.3. Home Health Management
  8.3.4. Financial Health Management

9. BY END-USER

9.1. Introduction
9.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
9.3. Market Attractiveness Index, By End-user
  9.3.1. Individual Users *
    9.3.1.1. Introduction
    9.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2020-2027
  9.3.2. Providers
    9.3.2.1. Hospitals
    9.3.2.2. Physicians
  9.3.3. Payers
    9.3.3.1. Private
    9.3.3.2. Government
  9.3.4. Other End Users

10. BY THERAPEUTIC AREA

10.1. Introduction
10.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapeutic Area
10.3. Market Attractiveness Index, By Therapeutic Area
  10.3.1. Chronic Diseases *
    10.3.1.1. Introduction
    10.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2020-2027
    10.3.1.3. Diabetes
    10.3.1.4. Cardiovascular Disease
    10.3.1.5. Obesity (Weight Loss Management)
    10.3.1.6. Other Chronic Diseases
  10.3.2. Women's Health
  10.3.3. Fitness
  10.3.4. Other Therapeutic Areas

11. BY REGION

11.1. Introduction
11.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
11.3. Market Attractiveness Index, By Region
11.4. North America
  11.4.1. Introduction
  11.4.2. Key Region-Specific Dynamics
  11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product component
  11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Mode of Delivery
  11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
  11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapeutic Area
  11.4.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    11.4.8.1. The U.S.
    11.4.8.2. Canada
    11.4.8.3. Mexico
11.5. Europe
  11.5.1. Introduction
  11.5.2. Key Region-Specific Dynamics
  11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product component
  11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Mode of Delivery
  11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
  11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapeutic Area
  11.5.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    11.5.8.1. Germany
    11.5.8.2. U.K.
    11.5.8.3. France
    11.5.8.4. Italy
    11.5.8.5. Spain
    11.5.8.6. Rest of Europe
11.6. South America
  11.6.1. Introduction
  11.6.2. Key Region-Specific Dynamics
  11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product component
  11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Mode of Delivery
  11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
  11.6.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapeutic Area
  11.6.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    11.6.8.1. Brazil
    11.6.8.2. Argentina
    11.6.8.3. Rest of South America
11.7. Asia-Pacific
  11.7.1. Introduction
  11.7.2. Key Region-Specific Dynamics
  11.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product component
  11.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Mode of Delivery
  11.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  11.7.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
  11.7.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapeutic Area
  11.7.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    11.7.8.1. China
    11.7.8.2. India
    11.7.8.3. Japan
    11.7.8.4. Australia
    11.7.8.5. Rest of Asia Pacific
11.8. Middle East and Africa
  11.8.1. Introduction
  11.8.2. Key Region-Specific Dynamics
  11.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product component
  11.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Mode of Delivery
  11.8.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  11.8.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
  11.8.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapeutic Area

12. GLOBAL MARKET COMPETITIVE LANDSCAPE

12.1. Competitive Scenario
12.2. Comparative Product component Portfolio Analysis
12.3. Market Positioning/Share Analysis
12.4. Mergers and Acquisitions Analysis

13. COMPANY PROFILES

13.1. Allscripts Healthcare Solutions, Inc*
  13.1.1. Company Overview
  13.1.2. Product component Portfolio and Description
  13.1.3. Key Highlights
  13.1.4. Financial Overview
13.2. Athenahealth, Inc
13.3. Cerner Corporation
13.4. McKesson Corporation
13.5. Phytel, Inc
13.6. Orion Health Ltd
13.7. Lincor Solutions Ltd
13.8. GetWellNetwork, Inc
13.9. YourCareUniverse, Inc
13.10. MEDecision, Inc

14. PREMIUM INSIGHTS

15. DATAM INTELLIGENCE

15.1. Appendix
15.2. About Us and Services
15.3. Contact Us


More Publications